NEW YORK, Sept. 11 (GenomeWeb News) - AstraZeneca has licensed data from Genaissance Pharmaceutical's so-called STRENGTH study, the company said today.

Terms of the agreement call for AstraZeneca to receive non-exclusive access to the database, which it will use for "a limited period."

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.